Does QT Widening in the Langendorff-perfused Rat Heart Represent the Effect of Repolarization Delay or Conduction Slowing?

Journal of Cardiovascular Pharmacology

Volumn 42, Issue 5, 2003, Pages 612-621

  Farkas, András ^a   Curtis, Michael J ^b  

^a UNIVERSITY OF SZEGED   (Hungary)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Class I antiarrhythmics; Conduction slowing; Langendorff preparation; Myocardial ischemia; Potassium concentration; QT interval

Indexed keywords

ANTIARRHYTHMIC AGENT; FLECAINIDE; LIDOCAINE; POTASSIUM; POTASSIUM CHANNEL BLOCKING AGENT; QUINIDINE; SODIUM CHANNEL; SODIUM CHANNEL BLOCKING AGENT;

ANIMAL; ANIMAL TISSUE; ARTICLE; BIOASSAY; CONTROLLED STUDY; DRUG EFFECT; HEART; HEART CONDUCTION; HEART MUSCLE CONDUCTION SYSTEM; HEART MUSCLE ISCHEMIA; HEART RATE; HEART REPOLARIZATION; ISCHEMIA; ISOLATED HEART; LONG QT SYNDROME; MALE; METHODOLOGY; NONHUMAN; PATHOPHYSIOLOGY; PERFUSION; PHYSIOLOGY; POTASSIUM CURRENT; PRIORITY JOURNAL; QT INTERVAL; RAT; RAT STRAIN;

ANIMALS; HEART; HEART CONDUCTION SYSTEM; HEART RATE; LONG QT SYNDROME; MALE; PERFUSION; POTASSIUM; POTASSIUM CHANNEL BLOCKERS; RATS; RATS, WISTAR; SODIUM CHANNEL BLOCKERS;

EID: 0142139283     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-200311000-00006     Document Type: Article

References (53)

1. Curtis MJ, Hearse DJ. Reperfusion-induced arrhythmias are critically dependent upon occluded zone size: relevance to the mechanism of arrhythmogenesis. J Mol Cell Cardiol. 1989;21:625-637.
2. Curtis MJ, Hearse DJ. Ischemia-induced and reperfusion-induced arrhythmias differ in their sensitivity to potassium: implications for mechanisms of initiation and maintenance of ventricular fibrillation. J Mol Cell Cardiol. 1989;21:21-40.
3. Curtis MJ. Characterisation, utilisation and clinical relevance of isolated perfused heart models of ischemia-induced ventricular fibrillation. Cardiovasc Res. 1998;39:194-215.
4. + channel, erg. Circ Res. 1997;80:261-268.
5. k blocking drug, UK-68,798: potent in guinea pig but no effect in rat myocardium. J Cardiovasc Pharmacol. 1990;16:401-410.
6. K blockade as an antiarrhythmic mechanism: effects of UK66,914 on ischemia and reperfusion arrhythmias in rat and rabbit hearts. Br J Pharmacol. 1993;108:139-145.
7. Iost N, Virág L, Opincariu M, et al. Delayed rectifier potassium current in undiseased human ventricular myocytes. Cardiovasc Res. 1998;40:508-515.
8. Varró A, Lathrop DA, Hester SB, et al. Ionic currents and action potentials in rabbit, rat, and guinea pig ventricular myocytes. Basic Res Cardiol. 1993;88:93-102.
9. K1 blockade: a new antiarrhythmic mechanism? Effect of RP58866 on ventricular arrhythmias in rat, rabbit, and primate. Circulation. 1993;87:1979-1989.
10. Gussak I, Chaitman BR, Kopecky SL, et al. Rapid ventricular repolarization in rodents: electrocardiographic manifestations, molecular mechanisms, and clinical insights. J Electrocardiol. 2000;33:159-170.
11. + channel blocking actions of flecainide compared with those of propafenone and quinidine in adult rat ventricular myocytes. J Pharmacol Exp Ther. 1994;269:66-74.
12. + current in rat ventricle. Br J Pharmacol. 1995;115:335-343.
13. Rees SA, Curtis MJ. Tacrine inhibits ventricular fibrillation induced by ischemia and reperfusion and widens QT interval in rat. Cardiovasc Res. 1993;27:453-458.
14. Carmeliet E. Cardiac ionic currents and acute ischemia: from channels to arrhythmias. Physiol Rev. 1999;79:917-1017.
15. Perchenet L, Kreher P. Mechanical and electrophysiological effects of preconditioning in isolated ischemic/reperfused rat hearts. J Cardiovasc Pharmacol. 1995;26:831-840.
16. ATP channels open as a prominent and early feature during ischemia in the Langendorff-perfused rat heart? Basic Res Cardiol. 2000;95:250-260.
17. Clements-Jewery H, Hearse DJ, Curtis MJ. The isolated blood-perfused rat heart: an inappropriate model for the study of ischemia- and infarction-related ventricular fibrillation. Br J Pharmacol. 2002;137:1089-1099.
18. Suzuki J, Tsubone H, Sugano S. Characteristics of electrocardiographic changes with some representative antiarrhythmic drugs in adult rats. J Vet Med Sci. 1991;53:779-787.
19. Sun LS, Legato MJ, Rosen TS, et al. Sympathetic innervation modulates ventricular impulse propagation and repolarization in the immature rat heart. Cardiovasc Res. 1993;27:459-463.
20. Ridley PD, Curtis MJ. Anion manipulation: a new antiarrhythmic approach. Action of substitution of chloride with nitrate on ischemia- and reperfusion-induced ventricular fibrillation and contractile function. Circ Res. 1992;70:617-632.
21. max in guinea pig myocardium. Circ Res. 1985;56:696-703.
22. K1 blocker, RP58866, assessed using the rat dual coronary perfusion model. J Mol Cell Cardiol. 1995;27:2595-2606.
23. Oshita S, Sada H, Kojima M, et al. Effects of tocainide and lidocaine on the transmembrane action potentials as related to external potassium and calcium concentrations in guinea-pig papillary muscles. Naunyn Schmiedebergs Arch Pharmacol. 1980;314:67-82.
24. Matsuo S, Koh Y, Sato R, et al. Electrophysiological effects of flecainide on guinea pig ventricular muscle in high [K+]o, acidosis and hypoxia. Jpn Heart J. 1987;28:539-554.
25. max recovery from use-dependent block by pirmenol in guinea pig papillary muscles: comparison with other class 1 drugs. J Cardiovasc Pharmacol. 1992;19:140-147.
26. Farkas A, Curtis MJ. Limited antifibrillatory effectiveness of clinically relevant concentrations of class 1 antiarrhythmics in isolated perfused rat hearts. J Cardiovasc Pharmacol. 2002;39:412-424.
27. Dinh HA, Murphy ML, Baker BJ, et al. Efficacy of propafenone compared with quinidine in chronic ventricular arrhythmias. Am J Cardiol. 1985;55:1520-1524.
28. Lie KI, Wellens HJ, van Capelle FJ, et al. Lidocaine in the prevention of primary ventricular fibrillation. A double-blind, randomized study of 212 consecutive patients. N Engl J Med. 1974;291:1324-1326.
29. Woosley RL, Siddoway LA, Duff HJ, et al. Flecainide dose-response relations in stable ventricular arrhythmias. Am J Cardiol. 1984;53:59B-65B.
30. Singh BN, Opie LH, Marcus FI. Antiarrhythmic agents. In: Opie LH, ed. Drugs for the heart. 3rd ed. Philadelphia: WB Saunders, 1991:180-216.
31. Benet LZ, Oie S, Schwartz JB. Design and optimization of dosage regimens: pharmacokinetic data. In: Hardman JG, Limbird LE, Molinoff PB, et al, eds. Goodman & Gilman's The Pharmacologic Basis of Therapeutics, 9th ed. New York: McGraw-Hill, 1996:1707-92.
32. Avkiran M, Curtis MJ. Independent dual perfusion of left and right coronary arteries in isolated rat hearts. Am J Physiol. 1991;261: H2082-H2090.
33. Akita M, Kuwahara M, Tsubone H, et al. ECG changes during furosemide-induced hypokalemia in the rat. J Electrocardiol. 1998;31:45-49.
34. Hirota M, Ohtani H, Hanada E, et al. Effects of hypokalemia on arrhythmogenic risk of quinidine in rats. Life Sci. 1998;62:2159-2169.
35. Yelamanchi VP, Molnar J, Ranade V, et al. Influence of electrolyte abnormalities on interlead variability of ventricular repolarization times in 12-lead electrocardiography. Am J Ther. 2001;8:117-122.
36. to blocker increases coronary flow independently of effects on heart rate, QT interval, and ischemia-induced ventricular fibrillation in rats. J Cardiovasc Pharmacol. 1993;22:343-349.
37. Farkas A, Qureshi A, Curtis MJ. Inadequate ischemia-selectivity limits the antiarrhythmic efficacy of mibefradil during regional ischemia and reperfusion in the rat isolated perfused heart. Br J Pharmacol. 1999;128:41-50.
38. + current inhibition in rat ventricular myocytes. J Pharm Pharmacol. 2000;52:99-105.
39. + conductance of the hyperpolarization-activated current in rabbit cardiac pacemaker cells. Pflugers Arch. 1992;421:97-99.
40. Hearse DJ, Stewart DA, Braimbridge MV. Hypothermic arrest and potassium arrest: metabolic and myocardial protection during elective cardiac arrest. Circ Res. 1975;36:481-489.
41. Ellwood AJ, Curtis MJ. The role of shear stress-independent release of nitric oxide in mediating drug-induced coronary vasodilatation can be assessed in the Langendorff constant pressure perfusion preparation. Med Sci Res. 1998;26:79-81.
42. Curtis MJ, Garlick PB, Ridley PD. Anion manipulation, a novel antiarrhythmic approach: mechanism of action. J Mol Cell Cardiol. 1993;25:417-436.
43. ATP channel blocker HMR 1098 on cardiac function in isolated perfused working rat hearts and in anesthetized rats during ischemia and reperfusion. Naunyn Schmiedebergs Arch Pharmacol. 2001;364:33-41.
44. Van Wagoner DR, Lamorgese M. Ischemia potentiates the mechanosensitive modulation of atrial ATP-sensitive potassium channels. Ann N Y Acad Sci. 1994;723:392-395.
45. Horner SM, Lab MJ, Murphy CF, et al. Mechanically induced changes in action potential duration and left ventricular segment length in acute regional ischemia in the in situ porcine heart. Cardiovasc Res. 1994;28:528-534.
46. + currents in isolated ventricular myocytes. Cardiovasc Res. 1996;32:930-939.
47. Morgan DJ, Huang JL. Albumin decreases myocardial permeability of unbound quinidine in perfused rat heart. J Pharmacol Exp Ther. 1994;268:283-290.
48. Huang JL, Morgan DJ. Influence of perfusion flow rate on uptake and pharmacodynamics of quinidine in isolated perfused rat heart. J Pharm Sci. 1994;83:119-123.
49. Barrett TD, Hayes ES, Walker MJ. Lack of selectivity for ventricular and ischemic tissue limits the antiarrhythmic actions of lidocaine, quinidine and flecainide against ischemia-induced arrhythmias. Eur J Pharmacol. 1995;285:229-238.
50. Barrett TD, Hayes ES, Yong SL, et al. Ischemia selectivity confers efficacy for suppression of ischemia-induced arrhythmias in rats. Eur J Pharmacol. 2000;398:365-374.
51. Haverkamp W, Breithardt G, Camm AJ, et al. The potential for QT prolongation and pro-arrhythmia by non-anti-arrhythmic drugs: clinical and regulatory implications. Report on a Policy Conference of the European Society of Cardiology. Cardiovasc Res. 2000;47:219-233.
52. Kr. Implications for torsade de pointes and reverse use-dependence. Circulation. 1996;93:407-411.
53. Curtis MJ, Barsby RW, Forster R. Protection by ITF 1300, a heparin ion-pair complex, against arrhythmias induced by regional ischemia and reperfusion in the isolated rat heart: possible mechanism of action. J Cardiovasc Pharmacol. 1995;25:643-651.